Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lister, T. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lister, T. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 8:S89-S92, 1997
© 1997 European Society for Medical Oncology

Follicular lymphoma: Grounds for optimism

T. A. Lister

ICRF Department of Medical Oncology, St Bartholomew's Hospital London, UK

1Correspondence to: Dr. T. A. Lister ICRF Department of Medical Oncology St Bartholomew's Hospital West Smithfield London EC1A 7BE, UK

The fact that follicular lymphoma is characterized by a specific immune phenotype and a nonrandom chromosomal translocation which may be detected at the molecular level makes it possible to design novel therapeutic strategies for curative therapy. Molecular markers may be used to test hypotheses. Some current causes for optimism are reviewed.

follicular lymphomas, t(14;18)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.